CSIMarket
 
Rvl Pharmaceuticals Plc  (RVLP)
Other Ticker:  
 
 
Price: $0.0282 $-0.01 -32.048%
Day's High: $0.038 Week Perf: -51.46 %
Day's Low: $ 0.03 30 Day Perf: -73.42 %
Volume (M): 63,964 52 Wk High: $ 1.45
Volume (M$): $ 1,804 52 Wk Avg: $0.57
Open: $0.04 52 Wk Low: $0.03



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 99
 Employees -
 Revenues (TTM) (Millions $) 36
 Net Income (TTM) (Millions $) -68
 Cash Flow (TTM) (Millions $) -8
 Capital Exp. (TTM) (Millions $) 3

Rvl Pharmaceuticals Plc
Rvl Pharmaceuticals Plc is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of various pharmaceutical products. The company focuses on the development of innovative drugs and therapies to address unmet medical needs across various therapeutic areas, including oncology, neuroscience, immunology, and rare diseases.

Rvl Pharmaceuticals Plc has a strong pipeline of drug candidates in various stages of development, and it actively seeks partnerships and collaborations with academic institutions, biotechnology companies, and other pharmaceutical companies to further enhance its research capabilities and expand its product portfolio.

The company is known for its commitment to quality and compliance with regulatory standards. It operates state-of-the-art manufacturing facilities and adheres to rigorous quality control measures to ensure the safety, efficacy, and reliability of its products.

Rvl Pharmaceuticals Plc has a global presence, with operations in multiple countries and a wide distribution network that enables it to reach patients worldwide. It is dedicated to improving patient outcomes and contributing to the overall advancement of healthcare through its innovative pharmaceutical solutions.


   Company Address: 400 Crossing Boulevard Bridgewater 8807 NJ
   Company Phone Number: 809-1300   Stock Exchange / Ticker: NASDAQ RVLP
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Rvl Pharmaceuticals Plc

Rvl Pharmaceuticals Plc Faces Major Setback with Losses Driven by Weak Sales Throughout Latest Fiscal Period



Investors holding shares in pharmaceutical giant Rvl Pharmaceuticals Plc may have mixed emotions as the company announced a widened deficit and considerable revenue decline for the April to June 30, 2023 financial span. However, hope emerges as Rvl Pharmaceuticals Plc's stock experiences positive gains in recent days and shows significant growth from the previous year.
Financial Results:
Rvl Pharmaceuticals Plc's financial report for the April to June 30, 2023 period revealed a deficit per share of $-0.24, a notable increase from $-0.14 per share reported a year ago. Moreover, compared to the preceding reporting season, the deficit rose from $-0.12 per share.

Rvl Pharmaceuticals Plc

Major Pharmaceutical Preparations Company Achieves Record-Breaking Liquidity Boost in Q1 2023 Earnings Season

Investors of Rvl Pharmaceuticals Plc are pleased to learn that the company's ability to collect its outstanding accounts receivable from corporate clients has significantly improved in the Mar 31 2023 quarter. The ratio of 14.81 represents a new company high, showing an improvement in liquidity at Rvl Pharmaceuticals Plc's clients. The average receivable collection period has also decreased to 25 days from the previous 47 days, indicating a strong performance in the healthcare sector.
It is worth noting that other companies in the healthcare sector have had a higher receivables turnover ratio than Rvl Pharmaceuticals Plc. However, the company's overall receivables turnover ratio total ranking has improved to 45, as compared to the fourth quarter of 2022.






 

Rvl Pharmaceuticals Plc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com